$1.67
+0.08 (+5.03%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,682.0% upside
Low Target
$33.82
Average Target
$46.46
High Target
$60.35
Current Price
$1.67
Current
$1.67
$1.67
Target
$46.46
$46.46
$33.82
$46.46 avg
$60.35
Scenario Analysis
Bear Case
$33.82
1,925.1%
Low target
Base Case
$46.46
+2,682.0%
Avg target
Bull Case
$60.35
+3,513.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$49.12
-96.6% from high
52-Week Low
$24.36
+-93.1% from low
Target vs 52W High
$46.46
-5.4% vs high
Next Earnings Report
Feb 19, 2026 · After Market Close
3d
until earnings
EPS Est: $0.05
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |